期刊文献+

肝细胞肝癌肺转移灶FDG摄取的假阴性分析 被引量:1

The false negative pulmonary metastases from primary hepatocellular carcinoma in FDG PET/CT imaging
下载PDF
导出
摘要 目的评价^(18)F-FDG PET/CT 探测原发性肝细胞肝癌(HCC)肺转移的价值,并分析肺转移灶 FDG 摄取假阴性的原因。方法 32例经手术病理或临床随访证实为 HCC 肺转移的患者行^(18)F-FDG PET/CT 检查,根据 FDG 摄取阳性或阴性分为2组:A 组18例,肺转移灶表现为 FDG 摄取增高;B组14例,肺转移灶表现为无 FDG 摄取。结果 32例 HCC 肺转移患者中,27例^(18)F-FDG PET/CT 显像发现肝内高代谢病灶,12例伴发其他肝外转移,其中包括腹膜后淋巴结、肺门或纵隔淋巴结、骨骼转移。PET 对最大径<10 mm 的肺转移灶探测灵敏度为35.6%,对最大径≥10 mm 的肺转移灶探测灵敏度为63.6%,两者比较,差异有统计学意义(χ~2=4.712,P=0.03)。肺转移灶的 FDG 摄取变异较大,从无 FDG 摄取到少数病灶的显著 FDG 摄取,83.3%(25/30)摄取阳性的转移灶最大 SUV(SUV_(max))≤3。结论 HCC 肺转移灶 FDG 摄取假阴性率较高,除与病灶大小有关外,可能与原发病灶的病理特点有关。呼吸控制的薄层 CT 图像以及必要时增强 CT 对肺部小结节的检出非常重要,对CT 显示小的肺结节病灶应严密随访。 Objective The purpose of this study was to evaluate the usefulness of PET/CT in detecting lung metastases from primary hepatocellular carcinoma ( HCC), and to analyze the false negative metastases with no uptake of FDG. Methods Thirty-two patients with lung metastases from HCC confirmed by histopathology examination or clinical follow-up were included in this study. The patients were categorized into group A, 18 patients having positive uptake of FDG; and group B, 14 patients being negative in FDG uptake. The patients received 18^ F-FDG intravenously after fasting for 4 to 6 h. Three-dimensional whole body PET/CT scans were acquired 60 min after injection. Results Twenty-seven of thirty-two patients showed hypermetabolic lesions in liver, indicating recurrence or viable tumor of hepatoceUular carcinoma. Twelve of thirty-two patients had other extrahepatic metastases, including post peritoneum, hilar and mediastinal lymph nodes and bone. The sensitivity of 18^ F-FDG PET was 35.6% for lung metastases smaller than 10 mm and 63.6% for lesions larger. The FDG uptake in the lung metastases was variable, 83.3% positive lung metastases had relatively lower FDG uptake with maximum SUV less than or equal to 3. Condusions This preliminary study showed that higher false negative rate of FDG uptake in lung metastases. It might be attributed to the smaller size and pathological characteristics of the lesions. Thin slice, contrast enhanced CT with breath-hold or careful clinical follow-up was recommended for detection of small lung metastases.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2007年第3期143-146,共4页 Chinese Journal of Nuclear Medicine
关键词 肝肿瘤 肿瘤转移 体层摄影术 发射型计算机 体层摄影术 X线计算机 脱氧葡萄糖 Liver neoplasms Neoplasm metastasis Lung Tomography, emission-computed Tomography, X-ray computed Deoxyglucose
  • 相关文献

参考文献10

  • 1Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol, 2000, 32: 792-797.
  • 2Teefey SA, Hildeboldt CC, Dehdashti F, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology, 2003, 226 : 533-542.
  • 3李家敏,孙启银,赵军,黄树林,王明芳,孙爱君.^(18)F-FDG PET显像在肝癌诊断及疗效评价中的应用[J].中华核医学杂志,1998,18(3):181-181. 被引量:8
  • 4徐白萱,田嘉禾,何义杰,刘雁翎,尹大一.FDG PET在肝脏恶性肿瘤诊断中的应用[J].中华核医学杂志,2002,22(3):139-140. 被引量:25
  • 5Katyal S, Oliver JH Ⅲ, Peterson MS, et al. Extraheptic metastases of hepatocellular carcinoma. Radiology, 2000, 216: 698-703.
  • 6Nomori H, Watanabe K, Ohtsuka T, et al. Evaluation of F-18 flurodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer, 2004, 45: 19-27.
  • 7Sugiyama M, Sakahara H, Torizuka T, et al. ^18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol, 2004, 39: 961-968.
  • 8Ho CL, Yu SC, Yeung DW. ^11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med, 2003,44 : 213-221.
  • 9Wever WD, Meylaerts L, Ceuninck LD, et al. Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone. Eur Radiol, 2007, 17 : 467-473.
  • 10程欣..肾透明细胞癌肺转移FDG PET显像不敏感二例..丁虹,赵军,管一晖..PET临床病例精选..香港:雅艺出版设计公司,,2002..90-91..

二级参考文献5

  • 1李家敏,中华核医学杂志,1997年,17卷,77页
  • 2李家敏,中华核医学杂志,1996年,16卷,136页
  • 3Delbeke D,Martin WH,Sandler MP,et al.Evaluation of benign vs malignant hepatic lesions with positron emission tomography[].Archives of Surgery.1998
  • 4Okazumi S,Isono K,Enomoto K,et al.Evaluation of liver tumors using 18 Ffluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment[].The Journal of Nuclear Medicine.1992
  • 5Torizuda,T,Tamaki N,Imokuma T,et al.Value of 18 F-FDG PET to monitor hepatocellular carcinoma after interventional therapy[].The Journal of Nuclear Medicine.1994

共引文献30

同被引文献5

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部